Skip To Main Content

Genesys

Electronic Circuitry
  • Home 
  • Genesys Ventures III

Identified through a call for expressions of interest from qualified managers to establish a new life sciences venture capital fund, OCGC selected the Genesys team as a leading candidate and committed $17 million to the Genesys Ventures III LP.

$17 Million
OCGC Investment
$90 Million
Partner Investment

Investment Impact

Careers Created & Retained Icon

210

Careers Created & Retained
Revenues Icon

$15 Million

Revenues
Research and Development Expenditures Icon

$23 Million

R & D Expenditures

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Portfolio

Adapsyn logo
EBT logo
Fairhaven logo
Flosonics logo
Fusion Pharmaceuticals logo
IDbyDNA logo
Inversago logo
Profound Medical logo
Genesys Capital (Fund Manager) logo